Victoria Balannik

VP Strategic Development and In licensing at Menarini-Stemline

Victoria is a biomedical strategy executive with significant experience in pharma innovation. Victoria leads Oncology BD with Menarini-Stemline, a global pharma company. Previously Victoria served as a Principal with aMoon Fund investing in pharma and health-tech platform companies, and as a Director of BD with BiolineRx. Prior to that Victoria was a research scientist with Amazon.Victoria earned PhD in Neuroscience from the Hebrew University and completed postdoctoral training in protein structure at Northwestern University.